Prosecution Insights
Prosecution Insights
4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (50%) |
| §112 only | 1 (25%) |
| No statute on record | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KIM, SEONG JONG | 1 | — | — |
| CHANDRAKUMAR, NIZAL S | 1 | 72.6% | +18.3% |
| HAVLIN, ROBERT H | 1 | 51.8% | +27.7% |
| MARTIN, KEVIN STEPHEN | 1 | 75.3% | +24.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18011454 | METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS | CHANDRAKUMAR, NIZAL S | 132d overdue |
| 17854721 | SHP2 Inhibitor Dosing and Methods of Treating Cancer | HAVLIN, ROBERT H | 34d |
| 17825875 | COVALENT RAS INHIBITORS AND USES THEREOF | MARTIN, KEVIN STEPHEN | — |
| Art Unit | Apps |
|---|---|
| 1626 | 2 |
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18769009 | RAS INHIBITORS | KIM, SEONG JONG | — | §112 | Non-Final OA | — | Pending | Jul 10, 2024 |
| 18011454 | METHODS FOR DELAYING, PREVENTING, AND TREATING ACQUIRED RESISTANCE TO RAS INHIBITORS | CHANDRAKUMAR, NIZAL S | 1625 | §103 | Final Rejection | 132d overdue | Pending | Dec 19, 2022 |
| 17854721 | SHP2 Inhibitor Dosing and Methods of Treating Cancer | HAVLIN, ROBERT H | 1626 | §103 | Non-Final OA | 34d | Pending | Jun 30, 2022 |
| 17825875 | COVALENT RAS INHIBITORS AND USES THEREOF | MARTIN, KEVIN STEPHEN | 1626 | — | Final Rejection | — | Pending | May 26, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial